Ultragenyx Pharmaceutical Inc.
RARE
DELAYED 1 MONTH
19 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 1 11:11 PM | Howard HornChief Financial Officer | Sale | 4,653 | $23.77 | $110.6K | 105,689(D) | View → |
| May 18, 2026 | May 18 10:41 PM | Shehnaaz SulimanDirector | Sale | 5,740 | $25.12 | $144.2K | 27,951(D) | View → |
| May 5, 2026 | May 6 6:51 PM | Eric CrombezEVP and Chief Medical Officer | Sale | 344 | $24.96 | $8.6K | 111,189(D) | View → |
| May 1, 2026 | May 4 9:35 PM | Howard HornChief Financial Officer | Sale | 4,683 | $24.90 | $116.6K | 110,342(D) | View → |
| Mar 10, 2026 | Mar 10 8:51 PM | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale | 3,508 | $22.67 | $79.5K | 66,820(D) | View → |
| Mar 6, 2026 | Mar 10 8:51 PM | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale | 6,018 | $21.40 | $128.8K | 70,328(D) | View → |
| Mar 2, 2026 | Mar 4 12:09 AM | John Richard PinionEVP, Chief Quality Operations Officer | Sale | 10,029 | $22.80 | $228.7K | 110,026(D) | View → |
| Mar 2, 2026 | Mar 4 12:08 AM | Erik HarrisEVP & Chief Commercial Officer | Sale | 10,539 | $22.80 | $240.3K | 89,515(D) | View → |
| Mar 2, 2026 | Mar 4 12:06 AM | Emil D KakkisDirector, President & CEO | Sale | 54,404 | $22.80 | $1.2M | 658,994(D) | View → |
| Mar 2, 2026 | Mar 3 11:51 PM | Karah Herdman ParschauerEVP and Chief Legal Officer | Sale | 8,135 | $22.80 | $185.5K | 76,346(D) | View → |
| Mar 2, 2026 | Mar 3 11:51 PM | Theodore Alan HuizengaSVP, Chief Accounting Officer | Sale | 1,632 | $22.80 | $37.2K | 48,670(D) | View → |
| Mar 3, 2026 | Mar 3 11:50 PM | Howard HornChief Financial Officer | Sale | 1,635 | $22.40 | $36.6K | 85,034(D) | View → |
| Mar 2, 2026 | Mar 3 11:50 PM | Howard HornChief Financial Officer | Sale | 8,409 | $22.70 | $190.9K | 86,669(D) | View → |
| Mar 2, 2026 | Mar 3 11:49 PM | Eric CrombezEVP and Chief Medical Officer | Sale | 7,029 | $22.80 | $160.3K | 76,301(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 18 10:50 PM | Matthew K FustDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:41 PM | Shehnaaz SulimanDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:39 PM | Amrit RayDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:38 PM | Corazon (Corsee) D. SandersDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:35 PM | Michael NarachiDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:23 PM | Daniel G WelchDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |
| May 14, 2026 | May 18 10:21 PM | Deborah DunsireDirector | Grant/Award | 14,058 | $25.80 | 14,058(D) | View → |